Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Patent 8420629 was granted and assigned to Incyte on April, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
Edits on 29 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 29 Nov, 2023
Edits made to:
Article (+322 characters)
Article

Patent abstract

The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.

Edits on 21 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 21 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
James D. Rodgers0
Stacey Shepard0
Edits on 7 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08420629 Azetidine and cyclobutane derivatives as JAK inhibitors US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Infobox
Patent Number
08420629
Patent Number
8420629
Edits on 16 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 16 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Incyte
Incyte
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08420629
Date of patent
April 16, 2013
Patent application number
13315750
Date Filed
December 9, 2011
Patent primary examiner
‌
Susanna Moore

Find more entities like US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.